Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03612284 · ClinicalTrials.gov registry record · NA
Scleral Contact Lens Insertion Solution Study
A NA study, sponsored by Jennifer Fogt.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03612284 is a NA study that has completed, run by Jennifer Fogt. The registered enrollment target is 30 participants.
The verdict
NCT03612284, a NA study, has completed, sponsored by Jennifer Fogt.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the clinical ocular compatibility (feasibility of safety and efficacy) of a patented solution (US Patent 2,259,437, Stone) which contains multiple essential ions and has a pH and tonicity which more closely mimics human tears as compared to the subjects' current habitual scleral lens insertion solution.
Interventions
- DEVICE contact lens insertion solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-11-27 |
| Est. Completion | 2018-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03612284
The ClinicalTrials.gov registry entry for NCT03612284 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jennifer Fogt, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which contact lens insertion solution is the first listed.
NCT03612284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03612284 about?
NCT03612284 is a clinical study titled "Scleral Contact Lens Insertion Solution Study". The purpose of this study is to determine the clinical ocular compatibility (feasibility of safety and efficacy) of a patented solution (US Patent 2,259,437, Stone) which contains multiple essential ions and has a pH and tonicity which more closely mimics human tears as compared to the subjects' cur...
What is the current status of trial NCT03612284?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-11-27. Estimated completion is 2018-11-30.
What interventions are being tested in trial NCT03612284?
The interventions under investigation include: contact lens insertion solution (DEVICE).
Who is sponsoring clinical trial NCT03612284?
This trial is sponsored by Jennifer Fogt, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.